Sonoma Pharmaceuticals, Inc. Income Statement
SNOA|15 years of annual SEC 10-K data (FY2011-FY2026)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Sonoma Pharmaceuticals, Inc. reported $14M in revenue and $3M in net loss for FY2026. Revenue has grown at a 2.6% compound annual rate over the past 15 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.3M | $12.7M | $13.3M | $12.6M | $18.6M | $17.9M | $19.0M | $16.7M | $12.8M | $9.4M | $13.9M | $13.7M | $15.5M | $12.7M | $9.8M |
| Cost of Revenue | $8.8M | $8.0M | $8.8M | $8.6M | $12.1M | $9.8M | $10.1M | $9.3M | $7.2M | $6.7M | $6.6M | $5.3M | $4.7M | $4.0M | $3.6M |
| Gross Profit | $5.5M | $4.7M | $4.5M | $4.0M | $6.6M | $8.1M | $8.9M | $7.3M | $5.7M | $2.6M | $7.3M | $8.4M | $10.7M | $8.7M | $6.1M |
| SG&A Expense | $7.4M | $7.6M | $8.8M | $9.8M | $9.5M | $14.2M | $18.6M | $19.9M | $17.1M | $15.6M | $12.4M | $11.6M | $11.9M | $13.2M | $11.6M |
| R&D Expense | $1.8M | $1.9M | $207.0K | $125.0K | $555.0K | $1.3M | $1.5M | $1.6M | $1.6M | $1.8M | $1.5M | $2.9M | $2.2M | $2.0M | $2.0M |
| Operating Income | -$3.7M | -$4.7M | -$4.6M | -$5.9M | -$3.4M | -$7.4M | -$11.3M | -$14.2M | -$13.0M | -$14.7M | -$6.7M | -$6.1M | -$3.4M | -$6.5M | -$7.5M |
| Interest Expense | - | - | - | -$10.0K | $4.0K | $16.0K | $33.0K | $40.0K | $3.0K | $3.0K | $3.0K | $1.1M | $1.1M | $931.0K | $406.0K |
| Income Tax | $550.0K | -$196.0K | -$33.0K | -$332.0K | $713.0K | $29.0K | $458.0K | $50.0K | -$4.3M | $0 | $0 | $0 | $0 | -$1.1M | - |
| Net Income | -$3.5M | -$4.8M | -$5.2M | -$5.1M | -$4.0M | -$3.3M | -$11.8M | -$14.3M | $9.3M | -$10.2M | -$8.2M | $3.7M | -$5.4M | -$7.3M | -$7.9M |
| EPS (Basic) | -$2.79 | -$10.63 | -$1.52 | -$1.92 | - | - | - | - | - | - | - | $0.54 | -$1.30 | - | - |
| EPS (Diluted) | -$2.79 | -$10.63 | -$1.52 | -$1.92 | - | -$2.24 | -$12.77 | -$28.49 | $2.20 | -$3.09 | -$0.85 | $0.54 | -$1.30 | -$1.87 | -$0.30 |
| Shares Outstanding | 1.6M | 780.4K | 4.9M | 3.1M | 2.1M | 1.8M | 1.3M | 685.7K | 4.3M | 4.2M | 15.0M | 8.2M | 6.6M | 4.1M | 26.6M |
| Gross Margin | 38.3% | 37.3% | 33.7% | 31.6% | 35.2% | 45.3% | 46.8% | 43.9% | 44.2% | 28.3% | 52.6% | 61.4% | 69.5% | 68.4% | 63.0% |
| Operating Margin | -26.0% | -36.9% | -34.4% | -46.6% | -18.5% | -41.2% | -59.4% | -85.2% | -101.2% | -157.1% | -48.1% | -44.3% | -21.8% | -50.7% | -76.9% |
| Profit Margin | -24.2% | -38.0% | -38.8% | -40.3% | -21.2% | -18.4% | -62.2% | -86.0% | 72.3% | -108.5% | -59.2% | 27.3% | -35.1% | -57.5% | -81.5% |